Please provide your email address to receive an email when new articles are posted on . VANCOUVER, British Columbia — A single subconjunctival 4 mg triamcinolone injection after retinal surgery had ...
To assess the long-term safety and efficacy of intravitreal triamcinolone acetonide injection in the management of macular oedema caused by central, hemi-, and branch retinal vein occlusion (CRVO, ...
A history of uveitis may increase the risk of developing sterile endophthalmitis after treatment with intravitreal triamcinolone acetonide for various retinal pathologies, according to a study by ...
To assess the intraocular pressure (IOP) changes, within the first 30 min after intravitreal injection of 0.1 ml (4 mg) triamcinolone, 0.09 ml (0.3 mg) pegaptanib, and 0.05 ml (1.25 mg) bevacizumab. A ...
May 7, 2003 — Intravitreal injection of triamcinolone is helpful in patients with refractory diabetic macular edema, according to a presentation on May 7 at the Association for Research in Vision and ...
December 22, 2009 — Intravitreal use of the corticosteroid triamcinolone may slow the progression of diabetic retinopathy, but adverse effects including cataract formation and glaucoma may prevent use ...
Injections of corticosteroids directly into the eye are superior to those placed adjacent to the eye for treating uveitic macular edema, one of the leading causes of blindness in the United States, a ...
Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Team Sky confirmed to Cyclingnews on Friday that members of staff from both organisations had ...
A report in the December issue of the Archives of Ophthalmology shows that injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results